NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-255-2012-0-PCT-02 Reversible Regulation Of Intein Activity Through Engineered New Zinc Binding Domain PCT PCT PCT/US13/053195 Expired
NIAID E-057-2011-2-US-02 Virus-Like Particles And Methods Of Use US National Stage 13/982,986 9487563 Issued PDF
NIDDK E-538-2013-0-US-01 Improved ELISA To Measure Hyaluronan US 61/860,722 Abandoned
NCI E-551-2013-0-PCT-02 Combination Therapty For The Treatment Of Cancer PCT PCT PCT/US13/052670 Abandoned
NHGRI E-013-2011-0-US-03 TRRAP And GRIN2A Mutations and Use Thereof for the Diagnosis and Treatment of Melanoma US National Stage 13/982,392 9157125 Issued PDF
NINDS E-030-2013-0-US-01 Selective Dopamine D2 Receptor Antagonists And Methods Of Their Use US 61/859,532 Abandoned
NCI E-166-2007-0-US-06 FILIP1L Nucleic Acid Fragments US DIV 13/952,192 9279009 Issued PDF
NCI E-029-2006-1-JP-13 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment JP DIV 2013-155750 Issued
NCI E-071-2009-0-US-04 Methods to Diagnose and Immunize Against the Virus Causing Human Merkel Cell Carcinoma US DIV 13/951,679 9156888 Issued PDF
NCI E-033-2008-0-US-07 Therapeutic Applications Of A P53 Isoform In Regenerative Medicine, Aging And Cancer US DIV 13/952,561 9068165 Issued PDF
NIAID E-021-2019-0-US-01 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US 61/858,533 Abandoned
NIAID E-120-2001-0-IN-84 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IN DIV 6683/DELNP/2013 Expired
NIAID E-081-2013-2-US-01 Prefusion RSV F Proteins And Their Use US 61/857,613 Abandoned
NCI E-215-2007-0-AU-12 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells AU DIV 2013207631 Abandoned
NCI E-014-2007-0-JP-26 SMOOTHENED POLYPEPTIDES AND METHODS OF USE JP DIV 2006-07-15 Abandoned
NICHD E-167-2009-3-US-02 METHODS FOR TREATMENT OF AUTISM SPECTRUM DISORDER US ORD 13/945,384 8987246 Issued PDF
NIAID E-540-2013-0-US-01 Methods and Compositions for Prevention of Allergic Reaction US 61/847,766 Abandoned
NCI E-157-2012-0-CA-05 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof CA National Stage 2879843 Issued
NCI E-157-2012-0-EP-06 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof EP National Stage 13819293.5 Abandoned
NCI E-157-2012-0-AU-03 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof AU National Stage 2013292695 Issued
NIEHS E-012-2011-0-US-03 Modulation of LRCH4 Activity and Therapeutic Application Thereof US National Stage 13/980,097 9211302 Issued PDF
NCI E-157-2012-0-PCT-02 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof PCT PCT PCT/US2013/050793 Expired
NHLBI E-175-2012-0-PCT-02 Method of Preparing Silca-Coated Nanodiamonds PCT PCT PCT/US2013/050779 Expired
NHLBI E-175-2012-0-EP-05 Method of Preparing Silca-Coated Nanodiamonds EP National Stage 13819376.8 Pending
NHLBI E-175-2012-0-JP-06 Method of Preparing Silca-Coated Nanodiamonds JP National Stage 2015-523199 Pending
NHLBI E-175-2012-0-CA-04 Method of Preparing Silca-Coated Nanodiamonds CA National Stage 2879407 Abandoned
NCI E-280-2007-0-US-03 Beta 1, 4-galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use US DIV 13/943,011 Abandoned
NCI E-321-2003-0-US-10 Human Cytolytic T-Lymphocyte Epitope And Its Agonist Epitope From The Non-Variable Number of Tandem Repeat Sequence of MUC-1 US DIV 13/941,705 9370559 Issued PDF
NIAID E-203-2010-0-US-04 METHOD FOR AMPLIFICATION AND DETECTION OF PRIONS US National Stage 13/979,843 Abandoned
NCI E-494-2013-0-US-01 Methods of Preparing Anti-Human Papillomavirus Antigen T Cells US 61/846,161 Abandoned
NCI E-495-2013-0-US-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors US 61/846,167 Abandoned
NIAID E-142-2008-0-US-04 Humanized Monoclonal Antibodies That Specifically Bind and/or Neutralize Japanese Encephalitis Virus (JEV) and Their Use US CON 13/941,283 9273121 Abandoned PDF
NEI E-105-2013-0-US-01 Surgical Tool For Ocular Tissue Transplantation US 61/845,598 Abandoned
NCI E-482-2013-0-US-01 PHOTOACTIVATABLE LIPID-BASED NANOPARTICLES AS VEHICLES FOR DUAL AGENT DELIVERY US 61/845,861 Abandoned
NIAAA E-210-2012-0-PCT-02 Intralipid As A Contrast Agent To Enhance Subsurface Blood Flow Imaging PCT PCT PCT/US13/050348 Expired
NCI E-121-2013-0-US-01 Method for the Diagnosis And Prognosis of Cancer US 61/845,055 Abandoned
NIDCR E-186-2009-0-US-01 Apototic Cell-Mediated Induction of Antigen-Specific Regulatory T Cells for the Therapy of Autoimmune Disease in Animals and Humans US 61/844,564 Abandoned
NICHD E-493-2013-0-US-01 Method for Predicting and Detecting Tumor Metastasis In Kidney Cancer US 61/844,534 Abandoned
NIAID E-074-2011-2-US-06 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS US National Stage 13/978,839 9181530 Issued PDF
NCATS E-083-2012-0-US-03 INHIBITORS OF EYA2 US National Stage 13/978,820 Abandoned
NCI E-767-2013-0-US-01 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules US 61/844,119 Abandoned
NINDS E-101-2012-1-US-01 Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) US 61/843,549 Abandoned
NCI E-119-2013-0-US-01 Method for Synthesizing Selectively Labeled RNA US 61/843,864 Abandoned
NIAID E-125-2008-0-US-04 MONOCLONAL ANTIBODIES THAT REACT WITH THE CAPSULE OF BACILLUS ANTHRACIS US CON 13/935,956 9273124 Abandoned PDF
NCI E-200-1998-0-US-34 Fitness Assay and Associated Methods US CON 13/933,319 9889115 Expired PDF
NIDCR E-066-1996-0-US-10 AAV4 VECTOR AND USES THEREOF US CON 13/933,382 8846389 Abandoned PDF
NIAID E-066-2013-0-US-01 Vaccine Comprising AMA1-RON2 US 61/841,479 Abandoned
NIAID E-019-2007-2-AU-12 Vaccines Against Potential Pandemic Strains Of Influenza AU DIV 2013206611 Abandoned
NHLBI E-274-2010-0-US-04 Single Channel MRI Guideware US National Stage 13/977,557 Abandoned
NCI E-090-2013-0-US-01 Systems and Methods of Video Monitoring for Vivarium Cage Racks US 61/841,064 Abandoned